Press Releases
Search
-
20 Jun 2013
bioMérieux receives CE marking for VIDAS® 3, the new generation of VIDAS®
Marcy l'Étoile, France, June 20, 2013 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, has been granted CE marking. This instru...
-
30 May 2013
bioMérieux Receives FDA Approval for THxIDTM-BRAF Companion Diagnostic Test
The only CE-marked and FDA-approved BRAF test able to simultaneously detect 2 BRAF mutations, V600E and V600K providing high medical value information to select treatment for metastatic melanoma patie...
-
21 May 2013
Nicolas Cartier appointed Corporate Vice President, Industrial Microbiology Unit of bioMérieux
Marcy l’Etoile, France, May 21, 2013 — A major player in the field of in vitro diagnostics and world leader in industrial microbiology, bioMérieux has announced the appointment of Nicolas Cartier as C...
-
23 Apr 2013
bioMérieux - First-Quarter 2013 Business Review
Stable sales in a persistently difficult European economy 2013 objective of 3-5% organic sales growth maintained Solid commercial negotiations underway Confirmed favorable growth prospects in emerging...
-
25 Mar 2013
Veolia Environnement and bioMérieux initiate a research partnership to develop an innovative monitoring system for drinking water quality
Paris, Lyon, March 25, 2013 – At BIOVISION, the world life sciences forum, Veolia Environnement, global leader in water services and expert in environmental services, and bioMérieux, global player in ...
-
13 Mar 2013
biomerieux-2012-financial-results
2012 performance: objectives met Sales up 6.8% at constant exchange rates €260 million in operating income before non-recurring items €134 million in free cash flow Robust international expansion, par...